Hung, K., Yang, S., Wu, C., Wang, H., Yao, C., Liang, C., . . . Chuah, S. (2021). Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice. Infect Drug Resist.
Styl ChicagoHung, Kuo-Tung, et al. "Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter Pylori Treatment in Real World Clinical Practice." Infect Drug Resist 2021.
Citace podle MLAHung, Kuo-Tung, et al. "Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter Pylori Treatment in Real World Clinical Practice." Infect Drug Resist 2021.